Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$83.02 /

-1.31 (-1.55%)

14:11
02/25/21
02/25
14:11
02/25/21
14:11

Sarepta announces FDA approval of Amondys 45

Sarepta Therapeutics announced that the Food and Drug Administration has approved Amondys 45, an antisense oligonucleotide from Sarepta's phosphorodiamidate morpholino oligomer platform, indicated for the treatment of Duchenne muscular dystrophy in patients with a confirmed mutation amenable to exon 45 skipping. Amondys 45 is priced at parity with Sarepta's other approved exon-skipping treatments, the company said in a statement.

  • 25

    Feb

  • 01

    Mar

  • 01

    Mar

SRPT Sarepta
$83.02 /

-1.31 (-1.55%)

02/09/21 Morgan Stanley
Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley
01/12/21 Citi
Sarepta downgraded to Neutral from Buy at Citi
01/11/21
Fly Intel: Top five analyst downgrades
01/11/21 UBS
Sarepta downgraded to Neutral on 'unexpected negative' results at UBS

TODAY'S FREE FLY STORIES

Upgrade
Repsol upgraded to Neutral from Underweight at JPMorgan » 11:35
04/12/21
04/12
11:35
04/12/21
11:35
REPYY

Repsol

$12.11 /

-0.125 (-1.02%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REPYY Repsol
$12.11 /

-0.125 (-1.02%)

03/12/21 Deutsche Bank
Repsol initiated with a Buy at Deutsche Bank
03/05/21 Goldman Sachs
Repsol downgraded to Neutral from Buy at Goldman Sachs
03/03/21 JPMorgan
Repsol price target raised to EUR 12 from EUR 8.50 at JPMorgan
02/22/21 Berenberg
Repsol price target raised to EUR 9.70 from EUR 9 at Berenberg
Options
Canadian Solar put volume heavy and directionally bearish » 11:35
04/12/21
04/12
11:35
04/12/21
11:35
CSIQ

Canadian Solar

$42.07 /

-1.275 (-2.94%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CSIQ Canadian Solar
$42.07 /

-1.275 (-2.94%)

CSIQ Canadian Solar
$42.07 /

-1.275 (-2.94%)

03/23/21 Roth Capital
Canadian Solar price target raised to $55 from $50 at Roth Capital
03/23/21 Citi
Canadian Solar price target lowered to $63 from $71 at Citi
03/08/21 JPMorgan
Canadian Solar price target lowered to $46 from $54 at JPMorgan
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
CSIQ Canadian Solar
$42.07 /

-1.275 (-2.94%)

CSIQ Canadian Solar
$42.07 /

-1.275 (-2.94%)

CSIQ Canadian Solar
$42.07 /

-1.275 (-2.94%)

CSIQ Canadian Solar
$42.07 /

-1.275 (-2.94%)

Downgrade
Equinor downgraded to Neutral from Overweight at JPMorgan » 11:33
04/12/21
04/12
11:33
04/12/21
11:33
EQNR

Equinor

$19.17 /

+0.245 (+1.29%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EQNR Equinor
$19.17 /

+0.245 (+1.29%)

EQNR Equinor
$19.17 /

+0.245 (+1.29%)

03/12/21
Fly Intel: Top five analyst initiations
03/12/21 Deutsche Bank
Equinor initiated with a Buy at Deutsche Bank
03/12/21 Societe Generale
Equinor upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Equinor price target raised to NOK 210 from NOK 190 at JPMorgan
EQNR Equinor
$19.17 /

+0.245 (+1.29%)

Upgrade
Total upgraded to Overweight from Neutral at JPMorgan » 11:33
04/12/21
04/12
11:33
04/12/21
11:33
TOT

Total

$44.94 /

-0.06 (-0.13%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOT Total
$44.94 /

-0.06 (-0.13%)

TOT Total
$44.94 /

-0.06 (-0.13%)

04/01/21 Piper Sandler
Total price target raised to $60 from $54 at Piper Sandler
03/30/21 Morgan Stanley
Morgan Stanley cuts Total to Equal Weight, sees decline in gearing
03/30/21 Morgan Stanley
Total downgraded to Equal Weight from Overweight at Morgan Stanley
03/12/21 Societe Generale
Total a cheap, high-quality oil stock, says Societe Generale
TOT Total
$44.94 /

-0.06 (-0.13%)

TOT Total
$44.94 /

-0.06 (-0.13%)

Periodicals
Siemens Healthineers weighing sale of ultrasound unit, Bloomberg says » 11:28
04/12/21
04/12
11:28
04/12/21
11:28
SMMNY

Siemens Healthineers

$28.08 /

+0.125 (+0.45%)

The ultrasound unit that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMNY Siemens Healthineers
$28.08 /

+0.125 (+0.45%)

SMMNY Siemens Healthineers
$28.08 /

+0.125 (+0.45%)

03/16/21 HSBC
Siemens Healthineers upgraded to Buy from Hold at HSBC
02/23/21 UBS
Siemens Healthineers price target raised to EUR 46 from EUR 40 at UBS
02/08/21 Berenberg
Siemens Healthineers price target raised to EUR 55 from EUR 54 at Berenberg
02/08/21 Deutsche Bank
Siemens Healthineers price target raised to EUR 46 from EUR 43 at Deutsche Bank
SMMNY Siemens Healthineers
$28.08 /

+0.125 (+0.45%)

Options
Kinross Gold call volume above normal and directionally bullish » 11:25
04/12/21
04/12
11:25
04/12/21
11:25
KGC

Kinross Gold

$7.30 /

-0.11 (-1.48%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGC Kinross Gold
$7.30 /

-0.11 (-1.48%)

KGC Kinross Gold
$7.30 /

-0.11 (-1.48%)

02/11/21 Barclays
Kinross Gold price target raised to $10 from $9 at Barclays
02/10/21 JPMorgan
Kinross initiated with Overweight, added to Focus List at JPMorgan
02/08/21 Stifel
Kinross Gold price target lowered to C$14.50 from C$14.75 at Stifel
01/11/21 National Bank
Kinross Gold price target lowered to C$17.25 from C$18 at National Bank
KGC Kinross Gold
$7.30 /

-0.11 (-1.48%)

KGC Kinross Gold
$7.30 /

-0.11 (-1.48%)

KGC Kinross Gold
$7.30 /

-0.11 (-1.48%)

Conference/Events
JPMorgan retail/dept stores analyst holds analyst/industry conference call » 11:25
04/12/21
04/12
11:25
04/12/21
11:25

Retail/Dept Stores &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
The Executives Club of Chicago holds a virtual meeting » 11:20
04/12/21
04/12
11:20
04/12/21
11:20

The Executives Club of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Roth says Rapt Therapeutics' AACR presentations highlight broad potential » 11:19
04/12/21
04/12
11:19
04/12/21
11:19
RAPT

Rapt Therapeutics

$20.40 /

-0.54 (-2.58%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAPT Rapt Therapeutics
$20.40 /

-0.54 (-2.58%)

RAPT Rapt Therapeutics
$20.40 /

-0.54 (-2.58%)

03/12/21 H.C. Wainwright
Rapt Therapeutics price target raised to $32 from $30 at H.C. Wainwright
11/17/20 BMO Capital
Rapt Therapeutics price target lowered to $45 from $51 at BMO Capital
10/21/20 BMO Capital
Rapt Therapeutics price target raised to $51 from $40 at BMO Capital
09/02/20 Roth Capital
Rapt rise after Gilead deal with Jounce 'warranted,' says Roth Capital
RAPT Rapt Therapeutics
$20.40 /

-0.54 (-2.58%)

RAPT Rapt Therapeutics
$20.40 /

-0.54 (-2.58%)

Hot Stocks
Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes  11:18
04/12/21
04/12
11:18
04/12/21
11:18
TIRX

Tian Ruixiang

$92.80 /

+1 (+1.09%)

 
ShowHide Related Items >><<
TIRX Tian Ruixiang
$92.80 /

+1 (+1.09%)

  • 27
    Jan
TIRX Tian Ruixiang
$92.80 /

+1 (+1.09%)

Conference/Events
Economic Club of New York to host a virtual meeting » 11:17
04/12/21
04/12
11:17
04/12/21
11:17
GS

Goldman Sachs

$333.90 /

+3.05 (+0.92%)

Goldman Sachs President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$333.90 /

+3.05 (+0.92%)

GS Goldman Sachs
$333.90 /

+3.05 (+0.92%)

04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/08/21 Citi
Goldman Sachs price target raised to $390 from $370 at Citi
04/07/21 Barclays
Goldman Sachs price target raised to $420 from $392 at Barclays
04/01/21
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$333.90 /

+3.05 (+0.92%)

GS Goldman Sachs
$333.90 /

+3.05 (+0.92%)

GS Goldman Sachs
$333.90 /

+3.05 (+0.92%)

GS Goldman Sachs
$333.90 /

+3.05 (+0.92%)

Technical Analysis
NASDAQ market internals summary » 11:17
04/12/21
04/12
11:17
04/12/21
11:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 11:16
04/12/21
04/12
11:16
04/12/21
11:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Conference/Events
Federal Reserve Bank of Boston president speaks on the economy » 11:15
04/12/21
04/12
11:15
04/12/21
11:15

Boston Federal Reserve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Truist medical devices analysts hold an analyst/industry conference call » 11:13
04/12/21
04/12
11:13
04/12/21
11:13

Medical Devices Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Clear Blue Smiles partners with GreenSky Patient Solutions » 11:13
04/12/21
04/12
11:13
04/12/21
11:13
GSKY

GreenSky

$6.12 /

-0.06 (-0.97%)

GreenSky and Clear Blue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSKY GreenSky
$6.12 /

-0.06 (-0.97%)

GSKY GreenSky
$6.12 /

-0.06 (-0.97%)

03/11/21 Citi
GreenSky price target raised to $5 from $4 at Citi
11/16/20 Citi
GreenSky price target lowered to $3.50 from $4 at Citi
11/06/20 Wolfe Research
GreenSky initiated with an Underperform at Wolfe Research
11/05/20 Citi
GreenSky assumed with a Sell at Citi
GSKY GreenSky
$6.12 /

-0.06 (-0.97%)

GSKY GreenSky
$6.12 /

-0.06 (-0.97%)

Options
Call buyer slides into Valvoline position vs 50k share delta hedge » 11:10
04/12/21
04/12
11:10
04/12/21
11:10
VVV

Valvoline

$26.85 /

+0.36 (+1.36%)

Call buyer slides into…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VVV Valvoline
$26.85 /

+0.36 (+1.36%)

VVV Valvoline
$26.85 /

+0.36 (+1.36%)

03/22/21 Citi
Valvoline price target raised to $32 from $28 at Citi
02/08/21 Citi
Valvoline price target raised to $28 from $25 at Citi
02/04/21 Monness Crespi
Valvoline price target raised to $30 from $26 at Monness Crespi
01/11/21 Seaport Global
Valvoline downgraded to Neutral from Buy at Seaport Global
VVV Valvoline
$26.85 /

+0.36 (+1.36%)

Hot Stocks
Merck KGaA reports objective response rate of 36% for berzosertib » 11:06
04/12/21
04/12
11:06
04/12/21
11:06
MKGAY

Merck KGaA

$38.36 /

+ (+0.00%)

Merck KGaA announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

02/10/21 Berenberg
Merck KGaA initiated with a Hold at Berenberg
01/04/21 JPMorgan
Merck KGaA upgraded to Overweight from Neutral at JPMorgan
11/20/20 Pareto
Merck KGaA upgraded to Buy from Hold at Pareto
11/16/20 AlphaValue
Merck KGaA upgraded to Add from Reduce at AlphaValue
MKGAY Merck KGaA
$38.36 /

+ (+0.00%)

Hot Stocks
Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause  11:06
04/12/21
04/12
11:06
04/12/21
11:06
TIRX

Tian Ruixiang

$95.29 /

+3.49 (+3.80%)

 
ShowHide Related Items >><<
TIRX Tian Ruixiang
$95.29 /

+3.49 (+3.80%)

  • 27
    Jan
TIRX Tian Ruixiang
$95.29 /

+3.49 (+3.80%)

Options
Square call volume above normal and directionally bullish » 11:05
04/12/21
04/12
11:05
04/12/21
11:05
SQ

Square

$259.68 /

-2.08 (-0.79%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

04/09/21 Credit Suisse
Square price target raised to $290 from $270 at Credit Suisse
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Oddo BHF
Square initiated with a Neutral at Oddo BHF
04/07/21 Barclays
Barclays boosts Square target to $330 on potential for international upside
SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

SQ Square
$259.68 /

-2.08 (-0.79%)

General news
European Fixed Income Summary: » 11:05
04/12/21
04/12
11:05
04/12/21
11:05
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler » 11:02
    04/12/21
    04/12
    11:02
    04/12/21
    11:02
    ITOS

    iTeos Therapeutics

    $25.41 /

    -1.495 (-5.56%)

    Piper Sandler analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ITOS iTeos Therapeutics
    $25.41 /

    -1.495 (-5.56%)

    ITOS iTeos Therapeutics
    $25.41 /

    -1.495 (-5.56%)

    04/09/21 Piper Sandler
    AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
    04/05/21 Piper Sandler
    Piper Sandler continues to recommend iTeos Therapeutics into data
    03/25/21 Wedbush
    iTeos Therapeutics price target raised to $52 from $46 at Wedbush
    10/07/20 Baird
    iTeos Therapeutics initiated with an Outperform at Baird
    ITOS iTeos Therapeutics
    $25.41 /

    -1.495 (-5.56%)

    • 24
      Jul
    Recommendations
    Provention Bio price target lowered to $22.50 from $35 at Chardan » 11:02
    04/12/21
    04/12
    11:02
    04/12/21
    11:02
    PRVB

    Provention Bio

    $8.00 /

    +0.01 (+0.13%)

    Chardan analyst Gbola…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    04/09/21 SVB Leerink
    Provention Bio price target lowered to $16 from $26 at SVB Leerink
    04/09/21 RBC Capital
    Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice
    04/09/21 Cantor Fitzgerald
    Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald
    04/09/21 RBC Capital
    Provention Bio downgraded to Sector Perform from Outperform at RBC Capital
    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    • 14
      Jan
    • 18
      Jun
    PRVB Provention Bio
    $8.00 /

    +0.01 (+0.13%)

    Recommendations
    Sage Therapeutics essential tremor data 'a win,' says Piper Sandler » 10:58
    04/12/21
    04/12
    10:58
    04/12/21
    10:58
    SAGE

    Sage Therapeutics

    $74.43 /

    -2.3 (-3.00%)

    Piper Sandler analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    04/07/21 Piper Sandler
    Sage Therapeutics assumed with an Overweight at Piper Sandler
    02/26/21 Mizuho
    Sage Therapeutics downgraded to Neutral from Buy at Mizuho
    02/25/21 Oppenheimer
    Sage Therapeutics price target raised to $102 from $90 at Oppenheimer
    02/25/21 H.C. Wainwright
    Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright
    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    SAGE Sage Therapeutics
    $74.43 /

    -2.3 (-3.00%)

    Options
    Nautilus put volume heavy and directionally bearish » 10:55
    04/12/21
    04/12
    10:55
    04/12/21
    10:55
    NLS

    Nautilus

    $16.12 /

    -0.455 (-2.75%)

    Bearish flow noted in…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    03/19/21 Craig-Hallum
    Nautilus price target lowered to $25 from $30 at Craig-Hallum
    03/19/21 Roth Capital
    Nautilus price target lowered to $26 from $29 at Roth Capital
    03/19/21 William Blair
    Nautilus 2026 margin target sent shares down 10%, says William Blair
    03/19/21 Craig-Hallum
    Nautilus price target lowered to $25 from $30 at Craig-Hallum
    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    NLS Nautilus
    $16.12 /

    -0.455 (-2.75%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.